ATE304860T1 - Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung - Google Patents

Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung

Info

Publication number
ATE304860T1
ATE304860T1 AT02745002T AT02745002T ATE304860T1 AT E304860 T1 ATE304860 T1 AT E304860T1 AT 02745002 T AT02745002 T AT 02745002T AT 02745002 T AT02745002 T AT 02745002T AT E304860 T1 ATE304860 T1 AT E304860T1
Authority
AT
Austria
Prior art keywords
extract
thylacoids
inflammatory
compositions containing
modulating inflammation
Prior art date
Application number
AT02745002T
Other languages
English (en)
Inventor
Alain Andersen
Elyse Bissonnette
Rejean Drouin
Marc Purcell
Original Assignee
Purecell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002381830A external-priority patent/CA2381830A1/en
Application filed by Purecell Technologies Inc filed Critical Purecell Technologies Inc
Application granted granted Critical
Publication of ATE304860T1 publication Critical patent/ATE304860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02745002T 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung ATE304860T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30183201P 2001-07-02 2001-07-02
CA002381830A CA2381830A1 (en) 2002-04-15 2002-04-15 Compositions comprising thylakoids useful in the modulation of the inflammation process
PCT/CA2002/001009 WO2003004042A1 (en) 2001-07-02 2002-07-02 Compositions comprising thylakoids useful in the modulation of the inflammation process

Publications (1)

Publication Number Publication Date
ATE304860T1 true ATE304860T1 (de) 2005-10-15

Family

ID=25682856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745002T ATE304860T1 (de) 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung

Country Status (6)

Country Link
US (1) US7329423B2 (de)
EP (1) EP1401463B1 (de)
JP (2) JP4988144B2 (de)
AT (1) ATE304860T1 (de)
DE (1) DE60206270T2 (de)
WO (1) WO2003004042A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027944A1 (en) * 2003-09-22 2005-03-31 Purecell Technologies Inc. Oral compositions and route of administration for the delivery of a thylakoid extract
CA2609208C (en) * 2005-06-10 2016-10-18 Per-Ake Albertsson Use of plant cell membrane for the treatment of obesity
WO2007109893A1 (en) * 2006-03-27 2007-10-04 Les Technologies Biofiltre Inc. Plant extracts and uses thereof
WO2011093290A1 (ja) * 2010-01-26 2011-08-04 株式会社日清製粉グループ本社 抗炎症剤
CA2699676C (en) 2010-04-12 2018-07-17 Purgenesis Technologies Inc. The use of a photosynthetic cell extract in a cosmetic composition
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
JP2018536701A (ja) 2015-11-03 2018-12-13 グループ・サンテ・デヴォニアン・インコーポレイテッド 炎症性腸疾患の治療用のチラコイド抽出組成物及び製剤
WO2018081903A1 (en) * 2016-11-04 2018-05-11 Groupe Santé Devonian Inc. Composition for the prevention and/or treatment of cardiovascular diseases
WO2024239103A1 (en) * 2023-05-19 2024-11-28 Bio A3P Inc. Topical cream for treating dermatological conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2293852A1 (fr) * 1999-12-30 2001-06-30 Purecell Technologies Inc. Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant

Also Published As

Publication number Publication date
US20050048148A1 (en) 2005-03-03
US7329423B2 (en) 2008-02-12
JP2009298810A (ja) 2009-12-24
JP2004535458A (ja) 2004-11-25
DE60206270D1 (de) 2006-02-02
EP1401463B1 (de) 2005-09-21
JP4988144B2 (ja) 2012-08-01
WO2003004042A1 (en) 2003-01-16
EP1401463A1 (de) 2004-03-31
DE60206270T2 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
AR030185A1 (es) Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ATE357509T1 (de) Stimulierung von hämatopoietischen zellen im vitro
ATE304860T1 (de) Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
BR0317715A (pt) Composições e processos de uso de collajolie
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
MX9709874A (es) N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
EA200000768A1 (ru) ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
DK1104294T3 (da) Sammensatninger og Fremgangsmåder til behandling af unormal celleproliferation
BR0210209A (pt) Composições contendo zinco para uso antiviral
EA200300105A1 (ru) Нестероидные ингибиторы воспалений
GT200100039A (es) Inhibidor de la glucogeno fosforilasa.
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
PT1032414E (pt) Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
DK1019490T3 (da) Fremgangsmåder til modulering af hæmatopoese og vaskulær vækst
ES2188870T3 (es) Sustrato compuesto elastomero selectivamente conductor segun el eje z, reutilizable.
DE60234463D1 (de) Abgabe von hydrogel-zusammensetzungen aus feinsprühnebel
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
BR0205329A (pt) Composição lìquida formadora de pelìcula
ES2111175T3 (es) Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias.
ATE302215T1 (de) Modulatoren von intrazellulären entzündungs-, zelltod- und zellüberlebenswegen, die card- und kinase-domänen enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties